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Abstract 
Aims/Objectives: Cognitive deficits are now well documented in ecstasy (MDMA) users with type and 
relative demand of task emerging as important factors. The updating component of executive 
processes appears to be particularly affected. The study reported here used fNIRS imaging to 
investigate changes in cortical haemodynamics during memory updating. Method: Twenty Ecstasy 
users and 20 nonusers completed verbal and spatial memory updating tasks while brain blood 
oxygenation and deoxygenation change was measured using functional Near Infrared Spectroscopy 
(fNIRS). Results: There was no interaction between group and difficulty on the updating tasks, 
though there was a significant main effect of difficulty on both tasks. The effects of group 
approached significance on the verbal updating task. There were significant differences in blood 
oxygenation and deoxygenation change at optodes centred over the right and left DLPFC, with 
ecstasy users showing greater blood oxygenation than the other groups. Discussion: The lack of a 
behavioural difference on both tasks, but presence of blood oxygenation and deoxygenation 
changes in letter updating provides support for the notion that ecstasy-polydrug users are investing 
more effort to achieve the same behavioural output. Total lifetime dose was high, and recency of 
use was significantly related to most changes, suggesting that heavy and recent use may be 
particularly detrimental.  
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Introduction 
While cognitive deficits are now well documented in ecstasy users (Montgomery et al., 2005; 
Montgomery et al., 2010; Nulsen et al., 2011; Parrott, 2013; Reay et al., 2006), some studies report 
non-significant behavioural differences (Halpern et al., 2011; Roiser et al., 2007). However, recent 
research suggests that even in the absence of behavioural differences, there may be cognitive 
reallocation and changes in brain function (e.g. Burgess et al., 2011; Daumann et al., 2003; Jacobsen 
et al., 2004; Roberts et al., 2013a; Roberts et al., 2013b; Roberts et al., 2013c). Theoretical models of 
executive functioning have attempted to fractionate the central executive based on latent variable 
analysis of performance on executive function tasks. One of the most widely accepted frameworks 
proposed by Miyake et al. (2000) fractionate the central executive in to 3-component processes: 
shifting (the ability to shift attention back and forth between different tasks), inhibition (the ability 
to inhibit an automatic response) and updating (the ability to monitor and update the contents of 
working memory).  One of the most consistent executive deficits in ecstasy users is degradation of 
the updating process which requires monitoring and coding incoming information, assessing its 
relevance, and reviewing/amending the contents of working memory accordingly. The fundamental 
nature of memory updating is that it requires active manipulation of relevant information, rather 
than acting as a short-term store (Lehto, 1996; Miyake et al. 2000; Morris & Jones, 1990). Moreover, 
as the usefulness of working memory as a whole is related to the efficiency with which we maintain, 
monitor, and edit the online contents, the updating component is one of the most often used 
functions in cognition (Carretti et al., 2005).  
Previous research shows that ecstasy users appear to be impaired in memory updating, 
especially if key indicators of Miyake et al.’s (2000) executive framework are used. Montgomery et al. 
(2005) assessed updating using a running letter memory task and computation span, with ecstasy 
users performing significantly worse than non-users on both tasks. This was replicated by 
Montgomery and Fisk (2008), where ecstasy users not only performed worse on the memory 
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updating task, but indices of ecstasy use were also significantly related to performance (with heavier 
users exhibiting more impairment). Wareing et al. (2004) used computation and reading span tasks, 
analogous to Miyake et al.’s operation span task. Although no group differences were observed on 
the reading span measure, ecstasy users were significantly impaired on computation span. This was 
replicated by Fisk et al. (2004), where group differences in computation span remained significant 
after controlling for the use of other drugs, indicating that in this study memory updating 
performance was related to the use of ecstasy, and not other substances. However, some similar 
span tasks have shown no relation to ecstasy use (Dafters et al., 1999) and variants of the n-back 
task have also shown mixed results (Alting von-Geusau et al., 2004; Gouzoulis-Mayfrank et al., 2003). 
Daumann et al. (2003) used a 0-back, 1-back and 2-back condition. Again, there were no significant 
differences in terms of correct responses and reaction times between pure ecstasy users and 
polyvalent ecstasy users. In terms of fMRI activation during the 1-back task, polyvalent ecstasy users 
did not differ significantly from controls, however pure ecstasy users presented lower activations 
than controls in the inferior temporal and angular regions; additionally, pure users had lower signal 
changes in the striate cortex, and a higher BOLD response in the premotor cortex compared to 
polyvalent users. Similarly, during the 2-back condition, pure users showed lower activation in the 
angular gyrus. This suggests that while behavioural differences may not be present, there may be 
some changes in neural activation that mask these differences. A further study also found evidence 
for abnormal activation in the left hippocampus of 6 ecstasy users relative to 6 nonusers, which 
significantly negatively correlated with length of abstinence from ecstasy, indicating that as 
abstinence increased, the functioning of the inhibitory circuits of the hippocampus recovered 
(Jacobsen et al., 2004).   
A number of other studies have found that ecstasy users and nonusers perform comparably 
on tests believed to tap the updating executive component process. Using backward digit span no 
performance differences have been observed in many studies (Bhattachary & Powell 2001; 
Gouzoulis-Mayfrank et al., 2003; McCardle et al., 2004; Thomasius et al., 2003). Gouzoulis-Mayfrank 
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et al. (2000) found that ecstasy/cannabis users performed worse than nonuser controls. They were 
not impaired relative to cannabis only users (matched for cannabis use), and cannabis only users did 
not differ significantly from controls. Cumulative lifetime ecstasy dose and age of onset of cannabis 
use were significantly correlated with performance on this task. Thus it appears that some aspect of 
cannabis use may also affect performance on this task. This was supported by Croft et al. (2001) 
where no performance differences were observed between ecstasy/cannabis users, cannabis only 
users and drug-naïve controls on the backward digit span task. However, after forming a single drug-
using group (comprising of ecstasy/cannabis and cannabis only users), this group performed worse 
than controls, which the authors propose was more related to the use of cannabis rather than 
ecstasy. Using Backward Digit Span (BDS), Reay et al. (2006) found no performance differences 
between groups after controlling for the use of cannabis, cocaine, alcohol and tobacco. Similarly, 
Nulsen et al. (2011) observed no main effect of group and little predictive power of MDMA variables 
in regression analyses on BDS. Halpern et al. (2011) measured BDS in ecstasy users who had little 
“other drug” experience and non-users; ecstasy users performed worse than nonusers, though there 
was no effect of level of use and the results were subsequently rejected as too modest to 
demonstrate ecstasy related effects. Bedi and Redman (2008) used BDS and found no differences 
between cannabis polydrug, ecstasy polydrug and nonusers, though there were some weak negative 
semi-partial correlations between performance and lifetime ecstasy dose and LSD dose.  In addition, 
a number of prospective cohort studies from Wagner and co-workers (Wagner et al., 2013; 2015a; 
2015b) have found no differences between ecstasy users and nonusers in BDS at baseline, follow up, 
and no relationship between ecstasy use parameters and performance.   
Subtracting Serial Sevens (SSS) has been used by Curran and co-workers who found ecstasy 
users make significantly fewer subtractions than nonusers on this task (Curran & Travill 1997; Curran 
& Verheyden 2003), while Morgan et al. (2002) found that ecstasy users made significantly more 
errors on the task. In addition, Verdejo-Garcia et al. (2005) used a combined measure of updating 
and found that ecstasy use was an important contributory factor in deficits in working memory 
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updating among a clinical sample of poly-substance abusers. Indeed, severity of ecstasy use was the 
best predictor of performance on this dimension. 
In addition to behavioural measures, the present study uses functional Near Infrared 
Spectroscopy (fNIRS) to assess cognitive function. fNIRS is an optical neuroimaging technique that 
assesses cortical haemodynamic changes in response to cognitive demand (Ayaz et al., 2012). 
Infrared light is transmitted into the PFC at two wavelengths (850nm and 730nm), allowing 
estimation of oxygenated (oxy) and deoxygenated haemoglobin (deoxy-Hb). This makes fNIRS an 
appropriate imaging tool for investigating executive functioning. As neuronal activity and 
haemodynamic response are coupled, increases in neuronal activity can be inferred by an increase in 
oxy-Hb (Leff et al., 2011). The location of the activation is regionally specific, and thus the area of the 
cortex underlying a given optode is responsible for the observed oxy/deoxy-Hb changes there (Leff 
et al., 2011). The changes in oxy and deoxy-Hb differ in terms of what they reflect about cortical 
haemodynamics. An increase in Oxy-Hb from baseline levels infers an increase in blood flow – as an 
area becomes more active, an increase in glucose and oxygen utilisation results in an increase in the 
transport of both of these substances to an area of the brain and a subsequent surplus of 
oxygenation (Bunce et al., 2006; Fox et al., 1998). An increase in deoxy-Hb infers changes in oxygen 
utilisation in a particular area of the brain – as oxygen is withdrawn from the oxygenated 
haemoglobin to be used in the task at hand, there is a resultant increase in deoxy-Hb (Obrig & 
Villringer, 2003).  Previous research from our own group (Roberts et al., 2015) has shown that 
ecstasy users perform comparably to nonusers on a multitasking paradigm but have increased 
oxygen utilisation while performing the task.  
In summary, previous studies investigating memory updating in ecstasy users exhibit 
equivocal results. However, studies that utilised key indicators of Miyake et al.’s (2000) framework 
usually elucidated between-group differences. It was therefore predicted that ecstasy-polydrug 
users would perform worse than nonusers on spatial and letter updating tasks. In line with previous 
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studies showing changes in cortical haemodynamics during task performance, it was also predicted 
that ecstasy-polydrug users would have increased prefrontal cortical blood oxygenation change and 
increased deoxygenation change relative to nonusers.   
Design: 
For analysis of behavioural data and fNIRS data a between groups design was used.  The between 
groups factor was drug user group which consisted of 2 levels (Ecstasy users and drug naïve controls).  
Mixed ANOVA was performed on the behavioural data for both letter updating and spatial updating, 
with user group as between groups, list length (difficulty) as within and the scores as the dependent 
variables. The fNIRS data was analysed with univariate ANOVAs using mean oxy and deoxy-Hb 
changes from baseline as the dependent variables at the 4 different areas as detailed in the methods 
below.  
Participants: 
Twenty ecstasy users (mean age = 21.76, SD = 3.19, 11 = male), and 20 drug naïve controls (mean 
age = 19.68, SD = 1.89, 9 = male) were recruited via direct approach (e-mail) to University students.  
Participants were required to be between 18 – 29 years of age. For inclusion in the ecstasy/MDMA 
user group, participants must have used ecstasy/MDMA on at least 5 occasions over their lifetime 
(actual minimum = 6 tablets; mean total lifetime dose 1305.31 ±4951.61 tablets; average amount 
used in last 30 days – 3.8 ±4.63 tablets; frequency of use – 0.39 ±0.48 time per week) although they 
may have used a range of substances in addition to MDMA. For inclusion in the drug naïve control 
group participants must have never consumed any illicit drugs. 
Participants were asked to abstain from consuming ecstasy for a minimum of 7 days prior to testing. 
Participants were also requested to abstain from use of other illicit drugs for a minimum of 24 hours 
prior to participating and ideally 7 days (actual abstinence periods are reported in Table 2). 
Materials 
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Background Variables - tasks administered: 
The Background Drug Use Questionnaire is a self- report measure of drug use and other lifestyle 
variables. Estimates of total lifetime drug use of each drug consumed were calculated (as per 
Montgomery et al., 2005)  as well as totals for last 30 days drug use. Other background variables 
including health status, age and years of education were also obtained from this questionnaire. 
Several measures of sleep were taken including a sleep quality questionnaire which measured typical 
duration and quality of sleep (how many hours slept typically, how much sleep over the previous 3 
nights).  The Epworth Sleepiness Scale (Johns, 1991) is a measure of subjective daytime sleepiness, 
which investigates the chances of the individual falling asleep or dozing in various situations – a high 
score being indicative of greater daytime sleepiness. The Morningness-Eveningness Questionnaire 
(MEQ, Terman et al., 2001), originally developed by Horne & Östberg (1976) is a self-assessment of 
morningness or eveningness types in human circadian rhythm. A high score is indicative of a morning 
type, whereas a low score is suggestive of an evening type.  Finally the Karolinska Sleepiness Scale 
(Akerstedt & Gillberg, 1990), is a self-assessment of current sleepiness, and can be administered at 
different time points of the experiment (before and after completion of tasks)  to assess sleepiness.  
The above indices of sleep were taken to explore the relationship between sleepiness and cognition, 
and also to observe whether there are any differences between groups in their sleep patterns, as it 
has been suggested (Cole, et al., 2002) that lack of sleep (amongst other lifestyle variables) may 
underlie possible cognitive deficits in ecstasy using cohorts.  
State Anxiety, Arousal and Hedonic Tone (Depression) were measured using the state mood adjective 
checklist developed by Fisk & Warr (1996). Participants rated their feelings at the time of testing on 
a 5 point Likert scale from 1 = not at all, to 5 = extremely on several items related to each subscale.  
A high score on each subscale indicates increased hedonic tone/anxiety/arousal.  
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The NASA TLX (Task Load Index) (Hart & Staveland, 1988)  is a series of visual analogue scales 
measuring subjective workload post-task.  Participants are required to place a mark on a 100mm line 
to indicate perceived demand of each task on six subscales (mental demand, physical demand, 
temporal demand, personal performance rating, effort and frustration). This measure was used as it 
has been suggested that ecstasy users may be more susceptible to stress (Wetherell et al., 2012), 
and thus report increased cognitive effort. 
Raven’s Standard Progressive Matrices (Raven et al., 1998) is a measure of fluid intelligence which 
requires participants to solve a series of problems (5 sets of 12) with increasing difficulty. Symbolic 
sequences are presented with a part missing, the participant is required to select the correct missing 
part from 6 possible options.  This requires an understanding of the various elements involved and 
their interactions with one another. 
Letter span: Consonants appeared on a computer monitor sequentially and remained on screen for 
1.25s each.  Following a sequence of letters being presented, participants were required to recall the 
order in which the letters appeared. To begin with 3 sets of 2 letters are presented, this then 
progresses to 3 sets of 3 letters, then 3 sets of 4 letters and so on up until 3 sets of 7 letters are 
presented. Participants’ span is noted as the largest string of letters they can recall accurately on at 
least 2 of the 3 trials. 
 
Spatial span: Analogous to the letter span task, participants have to recall the positions of 
highlighted blocks in a Corsi block type arrangement in the order that they were presented in. 
Highlighted blocks appear on screen for 1.25s each. 
Updating Tasks 
The letter and spatial updating tasks were carried out using a similar procedure to Montgomery and 
Fisk (2008), whereby each participant’s letter and spatial span were first calculated prior to 
conducting the updating tasks. 
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Letter updating: Based on running span memory task (Morris & Jones, 1990) consonants appear on 
the computer screen in random sequences dependent upon the participant’s calculated letter span.  
Twenty-four trials are presented and in each the participants are unaware of the number of letters 
that will appear in the sequence (length of list).  Participants are required to recall the most recent n 
consonants in the order in which they appeared (where n is the participants calculated letter span).  
There are 4 sequence lengths; n, n + 2, n + 4 and n + 6 and 6 trials of each length were presented in 
randomised order. Points were awarded for a correctly identified letter recalled in the correct 
position of the sequence.   
Spatial updating: This computer-based task was again analogous to the letter updating task.  Spatial 
locations were highlighted on a Corsi block type arrangement in random sequences. Thirty trials 
were presented and again participants were unaware of the length of the sequence being presented 
each time, with the exception of 6 trials, in which participants were told how many spatial locations 
were going to be presented (in each case it was always the participant’s span that was the list length 
for the known length trials).  Again, participants were required to recall the last n (where n is the 
participants calculated spatial span) positions in the order that they were presented.  There were 6 
trials at each list length; known n, unknown n, n + 2, n + 4 and n + 6 and the order in which these 
appeared was randomised.  
For both tasks, the overall performance scores were a composite of performance on each 
level of difficulty of the task relative to the participants span divided by the number of levels of 
difficulty, to give a mean score.  For example, if a participant had a span of 5 on the letter updating 
task, this would yield 5 responses on each trial, therefore for each level of difficulty on the task, their 
total score would be divided by their span (in this case 5) to give a mean score of performance on 
each level of difficulty. 
Deployment of fNIRS 
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Changes in prefrontal blood oxygenation were monitored using a continuous wave fNIRS system 
developed by Drexel University (Philadelphia, PA) and supplied by Biopac systems (Goleta, CA, USA). 
The sensor had a temporal resolution of 500ms per scan (2Hz), with a source-detector separation of 
2.5cm allowing 1.25cm penetration depth (Ayaz et al., 2012). An fNIR100 control box and data 
acquisition and visualisation software COBI studio (Drexel university) were used during data 
collection (as per Ayaz et al., 2011; Ayaz et al., 2012) with a serial cable between display and 
acquisition PCs to identify task markers. Raw data from was pre-processed using fnirSoft (Ayaz, 
2010). After visually inspecting the data, any saturated channels were discarded. A low-pass filter 
(0.1Hz cut off) and a linear phase filter (order of 20) were used to remove high frequency noise and 
noise due to respiration (Ayaz et al., 2011; Ayaz et al., 2012). Using the modified Beer-Lambert law 
logarithm in fnirSoft (Ayaz, 2010), we calculated total blood oxygenation, deoxygenation and volume 
changes relative to baseline over the entire epoch for the 16 channels.  Mean oxy and deoxy-Hb 
changes from baseline were calculated over the whole task epoch for each channel for the fNIRS 
data. Following this, optodes were grouped together for analysis, for comparison of regions of the 
prefrontal cortex (PFC) (Optodes 1, 2, 3 and 4, were grouped together as the left dorsolateral 
prefrontal cortical (DLPFC) region. Optodes 5, 6, 7 and 8 were grouped together as the left PFC 
region. Optodes 9, 10, 11 and 12 were grouped together as the right PFC region and Optodes 13, 14, 
15 and 16 were grouped together as the right DLPFC region).  fNIRS data was analysed using a series 
of ANOVAs with group as the between groups variable and oxy and deoxy-Hb change for the 4 
groups of optodes as the dependent variables.  
Procedure 
Participants were required to attend the lab for a one off session lasting approximately 2 hours.  
Testing sessions commenced at 9am, 11.30am and 2pm, equal numbers of each group were tested 
at each time. Upon entering the lab participants were given an information sheet explaining what 
was involved in the study and written consent for their participation was obtained.  Following this 
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participants completed a battery of questionnaires in the following order; Background drug use 
questionnaire, sleep quality questionnaire, morningness-eveningness questionnaire, Epworth 
sleepiness scale, pre-test Karolinska sleepiness scale, state mood questionnaire and Raven’s 
progressive matrices. Participants then completed the letter span task and the spatial span task, the 
order in which these were given was randomised. The fNIRS headband was then fitted to the 
participants’ forehead. The fNIRS signals were displayed on a desktop computer running COBI studio 
(Drexel University) in an adjacent room to the testing room. Providing the signals from the fNIRS 
sensors were stable, a baseline of inactivity was recorded – this involved participants watching a 
video of planet earth accompanied with soothing music. Following this the letter updating and 
spatial updating tasks were completed (a baseline was taken prior to each task). After completing 
the tasks participants completed the post task Karolinska sleepiness scale and post task NASA TLX 
(one for each task). Finally participants were fully debriefed and were paid £20 in store vouchers. 
The study was approved by Liverpool John Moores University Research Ethics Committee, and was 
administered in accordance with the ethical guidelines of the British Psychological Society. 
Statistical analysis 
ANOVA was used to test for group differences in the background variables, with mixed ANOVA used 
for the Karolinska sleepiness scales and MANOVA for the NASA-TLX. Mixed ANOVA was used to 
analyse spatial and letter updating. A series of univariate ANOVAS and ANCOVAs, incorporating any 
group differences in background variables were implemented for the fNIRS data. To assess the 
relationship between indices of drug use and relative oxy and deoxy-Hb change, Spearman’s 
correlations were used.  
Results 
Socio-demographic information about the participants, sleep measures and scores of anxiety, 
depression and arousal from the mood scale are shown in Table 1. Indices of other drug and alcohol 
use are displayed in Table 2.  
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<<Insert Tables 1 and 2 about here>> 
One way ANOVA revealed no significant between group differences on several background variables 
including total score on letter span, spatial span, the ESS, total score on the MEQ, levels of anxiety, 
depression and total score on Raven’s Progressive Matrices (see Table 1 for F values).  However 
there were between group differences in age F(1,34) = 5.81, p<0.05 and average number of hours 
slept per night F(1,38) = 5.77, p<.05; ecstasy-polydrug users were on average 2 years older than non-
users and reported an hour less of sleep per night. In addition, ecstasy-polydrug users also reported 
lower levels of arousal on the day of testing F(1,38) = 6.42, p<.01. A mixed ANOVA was used to 
analyse the Karolinska sleepiness scale pre/post scores. There was no main effect of time, no 
significant time x group interaction, but a significant main effect of group, indicating that ecstasy-
polydrug users felt sleepier prior to testing and after testing F(1,34) = 12.49, p<.001. A MANOVA on 
the NASA-TLX scores for letter updating revealed a non-significant main effect F(6,29) = 0.78, p>.05, 
and all univariate comparisons were also non-significant. A MANOVA for the NASA-TLX scores on the 
spatial updating revealed a non-significant main effect F(6,31) = 1.01, p>.05, though differences in 
mental demand approached significance F(1,36) = 3.36, p = 0.07; this indicated that ecstasy-polydrug 
users found the task more mentally demanding that nonusers.  
Inspection of Table 2 shows that the ecstasy-polydrug users consumed a range of substances. 
If a participant was a regular user of a particular substance, they completed an inventory of prior use. 
However, if they felt that their use of that substance was occasional (<5 times in total) they did not 
complete this.1 Consequently, in addition to means of drug use indices, there are percentages of 
participants reporting ever having used a substance in Table 2. Univariate ANOVA on average weekly 
alcohol consumption revealed a significant between group difference F(1,38) = 5.28, p<0.05, 
reflecting higher average weekly alcohol consumption in ecstasy-polydrug users.  
                                                          
1 Participants were asked about their use of: alcohol, amphetamines, cannabis, cocaine, crack cocaine, 
dimethyltryptamine (DMT), gammahydroxybutyrate (GHB), herbal ecstasy, heroin, ketamine, LSD, mushrooms, 
amyl nitrate poppers, Prozac, Salvia Divinorum, benzodiazepines, tobacco, Viagra, steroids, any novel 
psychoactive substances (e.g. mephedrone, naphyrone) and any other substance that they had tried.  
14 
 
Behavioural Data Analysis 
Performance on the updating tasks was assessed using mixed ANOVA.  Data are displayed in Figure 1. 
For letter updating, mixed ANOVA with difficulty (4 levels) within groups and group (2 levels) 
between groups yielded a significant main effect of difficulty indicating that regardless of group, all 
participants performed worse at the longer list lengths F(3,36) = 23.82, p<.001. The difficulty x group 
interaction was non-significant F(3,36) = 1.09, p>.05, and the main effect of group approached 
significance F(1,38) = 2.34, p = .07 (1-tailed). For spatial updating, a mixed ANOVA (in this case 
difficulty had 5 levels) revealed a significant main effect of difficulty F(4,34) = 14.21, p<.001. 
However the difficulty x group interaction was non-significant F(4,34) = 0.46, p>.05, as was the main 
effect of group F(1,37) = 0.06, p>.05.  
<<Insert Figure 1 about here>> 
fNIRS Analysis 
Mean averages of oxygenated and deoxygenated blood changes from baseline across groups, for the 
updating tasks are displayed in Table 3 and also represented in Figure 2. Univariate ANOVAs were 
conducted on each region to assess between group differences in blood oxygenation and 
deoxygenation change from baseline for each task. F values and significance levels for all fNIRS 
analyses are also displayed in Table 3, and significant effects discussed below.  
<<Insert Figure 2 about here>> 
Letter Updating: 
There were no differences in oxy-Hb change in the LDLPFC, LPFC or RDLPFC during letter updating. 
There were however significant oxy-Hb changes in the RPFC F(1,33) = 2.95, p<.05 (1-tailed). 
Inspection of the means in Table 3 shows that this is because ecstasy-polydrug users show an 
increase in oxygenation relative to baseline compared to nonusers. Between group differences in 
deoxy-Hb change from baseline were apparent in the LDLPFC F(1,33) = 2.70, p<.05 (1-tailed), LPFC 
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F(1,33) = 6.24, p<.01, RPFC F(1,33) = 6.71, p<.01 and RDLPFC F(1,33) = 6.26, p<.05. Again, ecstasy -
polydrug users showed an increase from baseline in deoxy-Hb compared to nonusers. Given the 
significant differences in some background variables, the analyses were re-run including average 
hours of sleep per night, age, arousal and the Karolinska sleepiness scale (pre and post) as covariates. 
All oxygenation changes remained non-significant after removing variance due to these background 
variables. For deoxygenation change, in the LDLPFC, the difference which approached significance at 
p = 0.06 was no longer approaching significance, though none of the background variables were 
significant as covariates (p>.05 in all cases) F(1,28) = 3.03, p = 0.09. In the LPFC, average hours of 
sleep approached significance as a covariate F(1,28) = 3.12, p = 0.09; ecstasy-polydrug differences 
remained significant after controlling for all of the background variables F(1,28) = 8.49, p<.01. 
Differences in RPFC, F(1, 28) = 7.43, p<.01 and RDLPFC, F(1,28) = 7.21, p<.01 remained significant 
after control for all of the background variables, and no background variables were significant as 
covariates.  
Spatial Updating: 
For spatial updating, there were no significant differences in oxygenation change from baseline in 
any areas, F<1 in all cases. For the deoxygenation change, differences in the LDLPFC approached 
significance F(1,32) = 1.99, p = 0.08, showing a trend for ecstasy-polydrug users to have greater 
deoxygenation change. All other difference in deoxy-Hb change were non-significant F<1 in all cases. 
ANCOVA to control for differences in background variables in spatial updating did not change the 
statistical significance of the analyses; the difference which was approaching significance for 
deoxygenation change in the LDLPFC was non-significant after controlling for the background 
variables F(1,27) = .00, p>.05, though none of the background variables were significant as 
covariates. For deoxygenation change in the RPFC, arousal was significant as a covariate F(1, 18) = 
5.25, p<.05, but the ecstasy-polydrug group differences remained non-significant F(1,18) = 1.07, 
p>.05.  
16 
 
Correlations with background differences and indices of drug use. 
To investigate the role of background variables and recent and cumulative use of “other” drugs on 
cortical haemodynamics, Spearman’s bivariate correlations were used. Significant cortical oxy and 
deoxygenation changes were correlated with indices of ecstasy, cannabis, ketamine and cocaine use 
(frequency of use, total lifetime dose, amount used in the last 30 days). In addition, significant 
differences in the background variables age, alcohol consumption (units per week) and sleep (hours 
per night) were also correlated with haemodynamic changes. The correlation coefficients are 
displayed in Table 4.  
<Insert Table 4 about here> 
 Inspection of Table 4 shows that there were no significant correlations with the background 
variables, or indices or cocaine use, p>.05 in all cases. Frequency of ketamine use, frequency, total 
lifetime dose and recent use of cannabis were positively associated with oxygenation change in the 
RPFC during the verbal task. For the ecstasy use variables, frequency of use was significantly 
associated with oxygenation change in the RPFC and deoxygenation change in the LPFC and RPFC. 
Total lifetime dose of ecstasy was significantly associated with deoxygenation change in the RPFC, 
and recent use was significantly associated with all significant haemodynamic changes. Where there 
were significant correlations with indices of more than one drug, the strength of the correlations 
was compared using an asymptotic z-test (see, Lee & Preacher, 2013). The correlation between 
frequency of ecstasy use and RPFC oxygenation change was significantly stronger than the 
correlation with frequency of cannabis use z = 4.09, p<.001. The correlation between amount of 
ecstasy used in the last 30 days and RPFC oxygenation was significantly stronger than the correlation 
with cannabis used in the last 30 days, z = 2.45, p<.01. There was no significant difference between 
the strength of the correlations between frequency of ecstasy and ketamine use and RPFC 
oxygenation, z = 1.71, p >.05.    
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Discussion 
The present study found little evidence for behavioural impairment of executive function in 
human ecstasy-polydrug users. Ecstasy-polydrug users did however display differences in cortical 
blood oxygenation in areas of the prefrontal cortex compared to drug naïve controls, suggesting that 
their PFC is working harder to achieve the same behavioural response (Ayaz et al., 2011). There were 
a number of significant correlations with indices of drug use suggesting that level of ecstasy use and 
cannabis use contribute towards the observed effects.  
 As stated in the introduction, differences in memory updating are one of the most 
consistently found executive function deficits in ecstasy-polydrug users (Fisk et al., 2004; Gouzoulis-
Mayfrank et al., 2000; Montgomery et al., 2005; Montgomery & Fisk, 2008; Reay et al., 2006; 
Wareing et al., 2004). However in the present study, there were no group differences in overall 
performance in running memory. This is not in line with previous research employing this paradigm 
(e.g. Montgomery & Fisk, 2008). However, inspection of performance in Figure 1 shows that ecstasy-
polydrug users had lower mean letter recall (which approached significance) in the verbal running 
memory task, though not the spatial task.  Nonetheless, there were differences in prefrontal blood 
oxygenation and deoxygenation change during the letter updating task. Differences were seen in the 
RPFC oxygenation change, and all deoxygenation changes during letter updating. In all cases ecstasy-
polydrug users had higher blood oxygenation and deoxygenation change suggesting that they are 
working harder to achieve the same behavioural outcome. Indeed this has been seen in fMRI studies 
looking at memory updating, where ecstasy users had differences in activation despite equivalent 
behavioural performance (Daumann et al., 2003; Jacobsen et al., 2004) and also in EEG studies of 
other cognitive functions (Burgess et al., 2011). The results also provide further evidence for the 
possible localisation of ecstasy-related degradation (whether this is temporary or permanent). 
Salmon et al. (1996) saw an updating-related increase in activation in the mid DLPFC, left middle 
frontal regions, and the right frontal pole. Similarly, Van der Linden et al. (1999) found the most 
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significant increases in activation occurred in the left frontopolar cortex spreading to the left middle 
frontal area during a 4-item running memory task, while Postle et al. (2001)and Collette et al. (2005) 
both observe that updating tasks consistently activate the DLPFC. Despite the non-significant 
behavioural differences, ecstasy-polydrug users were showing increases in deoxygenation change in 
areas of the DLPFC during the task suggesting that it was the process of updating of working memory 
that was causing an increase in oxygen uptake from the cell and thus a net increase in 
deoxygenation. If we extrapolate what the increase in deoxygenation change could mean compared 
to an increase in oxygenation change, the non-significant differences in the latter reflect that there is 
no overall increase in blood flow to the site (Bunce et al., 2006). However, the significant difference 
in the former show that oxygenation turnover and utilisation by the cell is greater (Obrig & Villringer, 
2003). As such it is possible that a longer paradigm which required continuous updating (e.g. the n-
back task) with no inter-trial intervals would yield greater differences in oxygenation change in 
addition to those observed in deoxygenation change in the present study. Future research should 
seek to clarify this.  
Despite the differences in cortical haemodynamics, in light of the non-significant behavioural 
differences, it remains a possibility that participants did not follow instructions and failed to adopt 
an updating strategy as instructed. Ruiz et al. (2005) suggest that a recency strategy is used in 
running memory tasks (remembering those items that one saw most recently via phonological 
rehearsal) and have reported clear recency effects on letter and word memory-updating tasks, 
which are magnified with increasing list length (i.e. the recency strategy was more likely to be used 
for longer list lengths). However, Morris and Jones (1990) found that memory updating on a running 
memory task was not affected by articulatory suppression, and consequently concluded that 
updating was not performed by the articulatory loop but rather by the central executive. Given that 
Baddeley and Hitch (1993) maintain that recency is a short-term memory phenomenon and is not 
related to working memory, this does not support the use of a recency strategy in the present study.  
The lack of list length effects is in line with research in cognitive psychology showing that updating is 
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an all or nothing process and does not involve a cumulative increase in cognitive demand as list 
length increases (Fisk & Sharp, 2004).  
To investigate the effect of level of drug use on cortical haemodynamics, correlations were 
performed between indices of drug use and oxy and deoxy-Hb change, with interesting 
differentiations emerging. The three cannabis use variables that were entered all positively 
correlated with oxygenation change in the RPFC, with higher use associated with higher oxygenation 
change. As all of the cannabis users also used ecstasy, this provides evidence of the effect of 
concomitant use of cannabis on cortical haemodynamics, however in all cases except total lifetime 
cannabis dose and oxy-Hb change in the RPFC, the correlations with ecstasy use indices were 
stronger than those with cannabis. Indices of ecstasy use were significantly associated with all 
changes in cortical haemodynamics; frequency of use with RPFC oxygenation change and LPFC and 
RPFC deoxygenation change; lifetime dose with RPFC deoxygenation change and recent use with all 
significant haemodynamic changes. This is in line with recent studies from our own lab where 
recency of use was a significant predictor of oxy-Hb change during an inhibition task (Roberts & 
Montgomery 2015a) and a semantic access task (Roberts and Montgomery 2015b). While these 
correlations with individual indices of drug use are noteworthy, they do not capture the interactive 
effects of concomitant use of ecstasy and other drugs at the same time. For example, co-use of 
ecstasy and cannabis is purported to be neuroprotective, through a reduction in hyperthermia 
(Tourino et al., 2010) while co-use of ecstasy and cocaine is purported to increase MDMA-related 
oxidative stress (Peraile et al., 2013). Thus there are complex interactions between substances not 
reflected here, and future research should seek to investigate these. It is also worthy of note that 
the ecstasy-polydrug users had increases in oxy and deoxy-Hb relative to baseline over almost every 
area during both tasks. However, for the letter updating task, nonusers had decreased oxy and 
deoxy-Hb relative to baseline. As increased mental effort is usually accompanied with an increase in 
brain activation (Gevins & Smith, 2000), it remains a possibility that the nonusers found the task 
easier than the ecstasy users and did not thus invest mental effort in their performance.  
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The present study had a number of limitations. As with many studies in this area, the ecstasy 
users in this sample are polydrug users; thus it cannot be ruled out that these effects result from the 
co-use of other drugs. Correlations were performed between various indices of drug use and oxy-Hb 
and deoxy-Hb change. In most cases, correlations with indices of ecstasy use were stronger than 
those for other drugs, with recency of use emerging as a particularly important factor. The use of 
self-reported drug use can also be criticised in terms of accuracy, especially given memory deficits 
that associated with substance use. This method is commonly used in this research area 
(Montgomery et al., 2005: Roberts et al., 2014). Where objective measures of substance use have 
been collected in our previous work, low levels of recent use were found in participants’ urine, and 
exclusion of participants with positive screens did not change the significant effects (Roberts et al., 
2013).  
The present study provided further support for ecstasy-polydrug related changes in cortical 
haemodynamics during a memory updating task. These changes were present in the absence of 
behavioural deficits, and it is proposed that the changes reflect increased cognitive effort in ecstasy-
polydrug users. Indices of ecstasy use, in particular recency of use, emerged as significant factors in 
the deficits and future research should seek to clarify the role of recent use in any observed deficits.  
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Table 1 – Indices sleep quality, fluid intelligence and socio-demographic variables 
 Ecstasy Polydrug 
Users 
Drug Naïve Controls F(1,38) =  
Males:  n, % 11 (55)  9 (45)   
 Mean SD Mean SD  
Age 21.76 3.19 19.68 1.89 5.81, p<.05 
University degree: n (%) 3 (15)  1 (5)   
      
Employment status      
Student; n, (%) 19 (95)  20 
(100) 
  
Employed; n (%) 1 (5)  0 (0)   
Unemployed; n (%) 0 (0)  0 (0)   
      
Ravens SPM (max 60) 
 
48.15 5.00 49.40 4.89 0.64, p>.05 
Letter Span 4.95 1.23 4.90 1.25 0.02, p>.05 
Spatial Span 
 
4.75 1.02 4.65 0.67 0.13, p>.05 
Sleep Indices      
Sleep – Hours/night 6.90 1.49 8.15 1.78 5.77, p<.05 
ESS Score (maximum 24) 6.95 3.07 6.10 3.01 0.78, p>.05 
KSS before 5.32 1.49 4.15 1.35 Time: F(1,34) = 2.60, p>.05 
Time*group: F(1,34) = 0.20, 
p>.05 
Group: F(1,34) = 12.49, 
p<.001 
KSS after 6.00 1.37 4.74 1.88 
MEQ total 
 
40.00 9.54 44.80 9.21 2.62, p>.05 
Mood Adjective Checklist:       
Anxiety 7.95 2.63 7.85 2.39 0.02, p>.05 
Depression  9.35 2.08 8.35 2.41 1.97, p>.05 
Arousal 16.60 3.49 19.35 3.38 6.42, p<.01 
 
NASA-TLX Letter      
Mental Demand 78.28 19.50 77.89 14.90 0.01, p>.05 
Physical Demand 14.67 23.87 11.05 17.62 0.27, p>.05 
Temporal Demand 60.33 26.93 59.11 27.00 0.02, p>.05 
Effort 65.00 26.05 75.28 14.18 2.16, p>.05 
Performance 48.06 22.12 53.33 21.71 0.52, p>.05 
Frustration 49.17 26.01 39.72 22.15 1.38, p>.05 
NASA-TLX Spatial      
Mental Demand 85.84 14.06 75.00 21.59 3.36, p = 0.07 
Physical Demand 17.11 24.93 15.21 17.17 0.07, p>.05 
Temporal Demand 59.11 26.51 56.16 30.73 0.10, p>.05 
Effort 76.74 24.70 78.74 13.07 0.10, p>.05 
Performance 41.37 20.23 47.95 21.45 0.95, p>.05 
Frustration 52.21 22.63 40.26 20.65 2.89, p>.05 
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Table 2: Indices of Other drug use in ecstasy users, polydrug users and nonusers 
  
 Ecstasy Users Drug Naive  
 M SD n M SD n 
Ecstasy       
 Frequency (times/wk) 0.39 0.48 20 - - - 
 Last 30 days (tablets) 3.80 4.60 20 - - - 
 Total use (tablets) 1305.31 4951.61 20 - - - 
 Length of Use (weeks) 176.12 157.90 20 - - - 
 Time since last use (weeks) 
 
8.67 
(median 2.5) 
13.85 
(range 47.29) 
20 - - - 
Cannabis       
 Frequency (times/wk) 2.28 2.86 16 - - - 
 Last 30 days (joints) 33.81 57.61 16 - - - 
 Total use (joints) 4183.42 6353.33 16 - - - 
 Length of Use (weeks) 304.12 166.01 18 - - - 
 Time since last use (weeks) 
 
16.40 
(median 2) 
60.83 
(range 259.86) 
16 - - - 
Cocaine        
Frequency (times/wk) 0.32 0.47 12 - - - 
Last 30 days (lines) 9.38 26.30 13 - - - 
Total use (lines) 964.63 2876.88 14 - - - 
 Length of Use (weeks) 153.96 143.52 15 - - - 
 Time since last use (weeks) 
 
19.32 
(median 4) 
22.65 
(range 51.14) 
13 - - - 
Ketamine       
Frequency (times/wk) 0.39 0.79 6 - - - 
Last 30 days use (grams) 1.2 2.68 5 - - - 
Total use (grams) 118.73 249.71 9 - - - 
 Length of Use (weeks) 66.27 124.55 11 - - - 
 Time since last use (weeks) 
 
52.64 
(median 12) 
83.13  
(range 281) 
 
11 - - - 
Alcohol units p/w 23.05 28.00 20 8.33 6.15 20 
Alcohol time since last use 0.79 1.30 20 0.63 0.44 20 
       
% ever tried:        
 Alcohol 100 100 
 Amphetamine 40 0 
 Cannabis 85 0 
 Cocaine 75 0 
 DMT 10 0 
 Ketamine 55 0 
 LSD 25 0 
 Mushrooms 30 0 
 Poppers 40 0 
 Salvia 20 0 
 Mephedrone 60 0 
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Table 3: Mean Oxy and deoxy Hb Change (µm) 
  
Ecstasy 
Polydrug Users 
Nonusers 
 
Main Analysis ANCOVA 
  Mean  SD Mean  SD F p F p 
Spatial Updating 
          
(1,32)  (1,28)  
LDLPFC-OXY .94 1.26 .85 1.09 0.00  >.05 0.00 >.05 
LPFC-OXY .87 1.56 .02 1.14 0.20 >.05 2.73 >.05 
RPFC-OXY .75 1.31 .24 1.13 0.01 >.05 0.21 >.05 
RDLPFC-OXY .30 1.23 .36 1.08 0.31 >.05 0.00 >.05 
LDLPFC-DEOXY .37 .91 .44 1.18 1.99 =.08 0.15 >.05 
LPFC-DEOXY .06 1.15 .58 .99 0.60 >.05 1.36 >.05 
RPFC-DEOXY .21 .67 .33 .96 0.95 >.05 1.07 >.05 
RDLPFC-DEOXY -.14 1.44 .26 .93 0.95 >.05 0.83 >.05 
Letter Updating 
 
        
(1,33)    
LDLPFC-OXY .22 1.14 .28 1.22 0.03 >.05 0.01 >.05 
LPFC-OXY .21 1.17 -.05 1.38 0.37 >.05 0.36 >.05 
RPFC-OXY .45 1.57 -.40 1.36 2.95 <.05 2.03 <.05 
RDLPFC-OXY .77 1.49 .35 1.17 1.02 >.05 2.52 >.05 
LDLPFC-DEOXY .38 1.38 -.33 1.17 2.51 =.06 3.33 =.09 
LPFC-DEOXY .44 1.25 -.60 1.22 6.24 <.01 8.49 <.01 
RPFC-DEOXY .47 1.42 -.71 1.09 6.71 <.01 7.43 <.01 
RDLPFC-DEOXY .47 1.44 -.38 1.03 6.26 <.05 7.21 <.01 
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Table 4: Correlations between drug use, background variables and haemodynamic changes 
 RPFC-
OXY 
LDLPFC-
DEOXY 
LPFC-DEOXY RPFC-
DEOXY 
RDLPFC-
DEOXY 
Ecstasy      
Frequency (times/wk) .313* .200 .278* .334* .275 
Lifetime dose (tablets) .182 .119 .226 .286* .206 
Current use (last 30 days) .364* .289* .482** .506** .428** 
      
Cannabis      
Frequency (times/wk) .305* -.036 .177 .237 .141 
Lifetime dose (joints) .355* -.060 .139 .210 .116 
Current use (last 30 days) .317* -.018 .212 .261 .180 
 
Cocaine       
Frequency (times/wk) .129 .058 .047 .055 .052 
Lifetime dose (grams) .216 .095 .126 .195 .147 
Current use (last 30 days) .147 -.174 -.109 -.072 -.124 
 
Ketamine      
Frequency (times/wk) .321* -.100 .045 .151 .044 
Lifetime dose (grams) .257 -.016 .167 .228 .119 
Current use (last 30 days) -.119 .068 -.017 -.034 -.034 
      
Average weekly alcohol (UK units) .026 .012 -.003 -.033 -.013 
Age (years) .003 -.061 -.177 -.119 -.130 
Average sleep per night (hours) .109 .135 .194 .014 .166 
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Figure 1: Mean items correctly recalled on spatial and letter updating.  
Letter Spatial 
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Figure 2: Mean cortical oxygenation and deoxygenation changes (µm) during Spatial and Letter Updating in the ecstasy-polydrug users and nonusers.  
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